The Latest
-
AstraZeneca Drops 3.5% Even As Covid-19 Vaccine Candidate Shows Promise in Trials
-
Fortress Biotech, Inc.’s (NASDAQ:FBIO) Path To Profitability
-
Last Minute Thought: Buy or Sell IBM Before Earnings?
-
Coronavirus update: AstraZeneca/Oxford vaccine shows promise; spiking cases ramp up fear factor